Metoprolol News
KV Pharmaceutical Issue Clarification On Citizen's Petition
Friday, KV Pharmaceutical Company, a specialty pharmaceutical company, provided clarification regarding the nature of a Citizen's Petition filed with the U.S. Food and Drug Administration. The company said the Citizen Petition...
FDA Approves New, Once-a-Day COREG CR for the Treatment of Three Key Cardiovascular Conditions
GSK and Flamel Technologies have announced FDA approval of once-a-day Coreg CR (carvedilol phosphate) extended-release capsules, for the treatment of three cardiovascular conditions: High blood pressure, also known as...
FDA Approves New Medical Use for Plavix
Drug Benefits Patients with Common Form of Heart Attack
Novartis' version of Toprol-XL wins OK
Novartis AG, the world’s second-largest generic drug maker, won U.S. approval of a version of AstraZeneca Plc’s Toprol-XL hypertension medicine.
Sustained restoration of autonomic balance with long- but not short-acting metoprolol in patients with heart failure.
The purpose of this study was to compare the effects of immediate-release (IR) metoprolol and extended-release (XL) metoprolol on measures of heart rate variability in chronic systolic heart failure patients.